Does Treatment at a Specialized Prosthetic Joint Infection Center Improve the Rate of Reimplantation
The Journal of Arthroplasty · 2023-06 · 38 (6) · S314-S317
DOI: 10.1016/j.arth.2023.03.082 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Arthroplasty, 2023-06. Verfasst von Thomas K Fehring und 6 weiteren Autor:innen. Beteiligte Einrichtung: OrthoCarolina - Hip & Knee Center, Charlotte, North Carolina; Atrium Health - Musculoskeletal Institute, Charlotte, North Carolina. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip, Arthritis, Infectious, Prosthesis-Related Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Two-stage exchange arthroplasty is currently the preferred treatment method for periprosthetic joint infection (PJI). The effectiveness of this strategy in returning patients to premorbid function has recently been challenged. In a review of 18,535 PJI knee patients, 38% did not undergo reimplantation. In another review of 18,156 hip and knee PJI patients, 43% did not undergo reimplantation. These disturbing statistics led us to ask whether treatment at a specialized PJI center could improve the rate of reimplantation compared to the previously noted studies from large national administrative databases. METHODS: A retrospective review of our registry was performed to identify 390 patients who underwent a two-stage exchange after total knee arthroplasty and total hip arthroplasty who had a confirmed chronic bacterial PJI, defined by Musculoskeletal Infection Society criteria, from January 2010 through December 2019. Variables included number of joints resected, number reimplanted, and the number not reimplanted. RESULTS: Of the 390 patients undergoing 2-stage treatment, 386 of 390 (99%) were reimplanted and 4 of 390 (1%) were not reimplanted due to medical issues. CONCLUSION: We have shown that 2-stage treatment at a PJI center significantly improves the rate of reimplantation. A specialized PJI center with experienced revision surgeons doing high volume infection procedures complemented by infectious disease and medical consultants familiar with the special needs of PJI patients may be advantageous. A national network of such centers may have the ability to improve outcomes, standardize treatment protocols, and allow for collaborative research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- OrthoCarolina - Hip & Knee Center, Charlotte, North Carolina; Atrium Health - Musculoskeletal Institute, Charlotte, North Carolina.
- OrthoCarolina - Hip & Knee Center, Charlotte, North Carolina.
- OrthoCarolina Research Institute, Charlotte, North Carolina.
Zitieren
APA
Fehring, T. K., Otero, J. E., Curtin, B. M., Fehring, K. A., Metcalf, R., Rowe, T. M., & Springer, B. D. (2023). Does Treatment at a Specialized Prosthetic Joint Infection Center Improve the Rate of Reimplantation. The Journal of Arthroplasty, 38(6), S314-S317. https://doi.org/10.1016/j.arth.2023.03.082
Vancouver
Fehring TK, Otero JE, Curtin BM, Fehring KA, Metcalf R, Rowe TM, et al. Does Treatment at a Specialized Prosthetic Joint Infection Center Improve the Rate of Reimplantation. The Journal of Arthroplasty. 2023;38(6):S314-S317. doi:10.1016/j.arth.2023.03.082
BibTeX
@article{Fehring2023,
author = {Fehring, Thomas K and Otero, Jesse E and Curtin, Brian M and Fehring, Keith A and Metcalf, Rory and Rowe, Taylor M and Springer, Bryan D},
title = {Does Treatment at a Specialized Prosthetic Joint Infection Center Improve the Rate of Reimplantation},
journal = {The Journal of Arthroplasty},
year = {2023},
volume = {38},
number = {6},
pages = {S314--S317},
doi = {10.1016/j.arth.2023.03.082}
}
EUVIMED